Clinical Outcomes of Patients with Giant Cell Arteritis Treated with Tocilizumab in Real-World Clinical Practice

被引：0
|
作者：
Unizony, Sebastian H. [1 ]
Pei, Jinglan [2 ]
Sidiropoulos, Paris N. [2 ]
Best, Jennie H. [2 ]
Birchwood, Christine [2 ]
Stone, John H. [3 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA USA
[2] Genentech Inc, San Francisco, CA 94080 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, Rheumatol Med, Boston, MA USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2018年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2760
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Clinical, Laboratory and Imaging Outcomes in Tocilizumab-Treated Patients with Large Vessel-Giant Cell Arteritis According to Early Onset Therapy
    Prieto-Pena, Diana
    Martinez-Rodriguez, Isabel
    Atienza-Mateo, Belen
    Gomez De la Fuente, Francisco Javier
    Sanchez-Salmon, Aida
    Angel Gonzalez-Gay, Miguel
    Blanco, Ricardo
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 2933 - 2935
  • [42] CLINICAL OUTCOMES OF PATIENTS WITH GIANT CELL ARTERITIS WITH POLYMYALGIA SYMPTOMS ONLY VS CRANIAL SYMPTOMS ONLY TREATED WITH TOCILIZUMAB OR PLACEBO IN THE GIACTA TRIAL
    Spiera, Robert
    Unizony, Sebastian
    Bao, Min
    Luder, Yves
    Sidiropoulos, Paris
    Pei, Jinglan
    Stone, John H.
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 811 - 811
  • [43] Allergen immunotherapy: Clinical outcomes data from a real-world clinical practice
    Silva, Pedro
    Nogueira, Celia
    CLINICAL AND EXPERIMENTAL ALLERGY, 2022, 52 (08): : 1016 - 1016
  • [44] ALLERGEN IMMUNOTHERAPY: CLINICAL OUTCOMES DATA FROM A REAL-WORLD CLINICAL PRACTICE
    Silva, P.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2021, 127 (05) : S24 - S24
  • [45] CLINICAL, LABORATORY AND IMAGING OUTCOMES IN TOCILIZUMAB-TREATED PATIENTS WITH LARGE VESSEL-GIANT CELL ARTERITIS ACCORDING TO EARLY ONSET THERAPY
    Prieto-Pena, D.
    Martinez-Rodriguez, I.
    Atienza-Mateo, B.
    Cuenca-Vera, O.
    Gomez de la Fuente, F. J.
    Sanchez-Salmon, A.
    Gonzalez-Gay, M. A.
    Blanco, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 1208 - 1208
  • [46] TOCILIZUMAB FOR GIANT CELL ARTERITIS: REAL WORLD EXPERIENCE IN A SINGLE UK CENTRE
    Reynolds, Gary
    Griffiths, Bridget
    Houghton, Karolyn
    Thompson, Ben
    Lorenzi, Alice R.
    Heaney, Jonathan
    RHEUMATOLOGY, 2020, 59
  • [47] Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice
    Grannell, Andrew
    Al-Najim, Werd
    le Roux, Carel
    CLINICAL OBESITY, 2023,
  • [48] Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
    Daichi Tamura
    Noriaki Jinnouchi
    Masakazu Abe
    Daiki Ikarashi
    Tomohiko Matsuura
    Renpei Kato
    Shigekatsu Maekawa
    Yoichiro Kato
    Mitsugu Kanehira
    Ryo Takata
    Wataru Obara
    International Journal of Clinical Oncology, 2020, 25 : 899 - 905
  • [49] Prognostic outcomes and safety in patients treated with pembrolizumab for advanced urothelial carcinoma: experience in real-world clinical practice
    Tamura, Daichi
    Jinnouchi, Noriaki
    Abe, Masakazu
    Ikarashi, Daiki
    Matsuura, Tomohiko
    Kato, Renpei
    Maekawa, Shigekatsu
    Kato, Yoichiro
    Kanehira, Mitsugu
    Takata, Ryo
    Obara, Wataru
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (05) : 899 - 905
  • [50] Long-term weight outcomes in patients treated with liraglutide 3.0 mg in real-world clinical practice
    Grannell, Andrew
    Al-Najim, Werd
    le Roux, Carel
    CLINICAL OBESITY, 2024, 14 (01)
12345